PCSA Processa Pharmaceuticals, Inc.
-
Processa Pharmaceuticals Reported Earnings
Friday, November 13, 2026 · 12:00 AM ET
Processa Pharmaceuticals (PCSA) reported a loss of $61.58 per share on revenue of $0.00 million for the . .
Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who have unmet medical need. Processa Pharmaceuticals Inc., formerly known as Heatwurx Inc., is based in HANOVER, United States.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($61.58)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—